2-219539625-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024536.6(CHPF):āc.2086G>Cā(p.Glu696Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,613,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024536.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHPF | NM_024536.6 | c.2086G>C | p.Glu696Gln | missense_variant | 4/4 | ENST00000243776.11 | NP_078812.3 | |
CHPF | NM_001195731.2 | c.1600G>C | p.Glu534Gln | missense_variant | 4/4 | NP_001182660.2 | ||
CHPF | XM_011511838.4 | c.1213G>C | p.Glu405Gln | missense_variant | 3/3 | XP_011510140.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHPF | ENST00000243776.11 | c.2086G>C | p.Glu696Gln | missense_variant | 4/4 | 1 | NM_024536.6 | ENSP00000243776 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152252Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000765 AC: 19AN: 248400Hom.: 0 AF XY: 0.0000742 AC XY: 10AN XY: 134836
GnomAD4 exome AF: 0.0000500 AC: 73AN: 1461248Hom.: 0 Cov.: 30 AF XY: 0.0000481 AC XY: 35AN XY: 726958
GnomAD4 genome AF: 0.000105 AC: 16AN: 152370Hom.: 0 Cov.: 34 AF XY: 0.0000940 AC XY: 7AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.2086G>C (p.E696Q) alteration is located in exon 4 (coding exon 4) of the CHPF gene. This alteration results from a G to C substitution at nucleotide position 2086, causing the glutamic acid (E) at amino acid position 696 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at